NOW, BREAKING NEWS FROM INFECTIOUS DISEASE CONFERENCE IN WASHINGTON, D.C. SIGNIFICANT NEW HIV AND AIDS STUDY RESULTS UNVEILED PHASE III STUDY FINDINGS ON ISENTRESS (RALTEGRAVIR), THE FIRST-IN-CLASS HIV TREATMENT, TO BE RELEASED BE THE FIRST TO TALK DIRECTLY TO A STUDY INVESTIGATOR Dr. Daniel Berger, study investigator and medical director of NorthStar Healthcare in Chicago, is available LIVE via satellite from Washington, D.C. to answer questions and explain the impact of these findings in patients who have never been treated for HIV. HIV and AIDS continues to be a national and worldwide epidemic. According to the most recent estimates, there are over one million cases of the disease in the U.S. alone, with approximately 56,000 new cases diagnosed each year. Worldwide, approximately 33 million people are infected with HIV and AIDS and more than two million new infections occurred in 2007. Sponsored by: Merck?